Company / R&D Expense
Personalis, Inc. R&D Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$50.3M
FY2025
5-year range
$49.3M / $64.9M
FY2021-FY2025
Trend
-22.4%
vs FY2024
Sector context
#81 of 110
Health Care
What the data says
At $50M, Personalis, Inc.'s r&d expense ranks #81 of 110 in the Health Care sector. R&D Expense has fluctuated over the past 9 years, ranging from $10M in FY2019 to $65M in FY2022.
Based on SEC 10-K filings.
$50M in FY2025 with a 5-year CAGR of +28.6%.
Remained stable around $50M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -8.2%
- 5-Year CAGR
- +28.6%
- 10-Year CAGR
- -
Sector benchmark
#81 of 110 in Health CareTop 74% of 110This company $50.3M Sector average $298.2M
▼
-83.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +28.6%, indicating consistent growth.
- In FY2025, r&d expense decreased 22.4% year-over-year.
- Ranks #81 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $50.3M | -22.4% |
| FY2024 | $64.8M | +31.4% |
| FY2023 | $49.3M | -24.0% |
| FY2022 | $64.9M | +31.6% |
| FY2021 | $49.3M | +244.7% |
| FY2020 | $14.3M | +44.2% |
| FY2019 | $9.9M | -30.7% |
| FY2018 | $14.3M | +44.2% |
| FY2017 | $9.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026